Lung Cancer Clinical Trial
Official title:
Respiratory Muscle Strength, Functional Capacity and Subjective Outcome - Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial
| Verified date | January 2015 |
| Source | Aalborg Universitetshospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Denmark: Danish Dataprotection Agency |
| Study type | Interventional |
The purpose of this study is to evaluate the effects of postoperative inspiratory muscle training on the recovery of respiratory muscle strength in high risk patients referred for lung cancer surgery. Furthermore, to assess longitudinal changes in respiratory muscle strength, physical capacity and health-related quality of life after lung cancer surgery
| Status | Completed |
| Enrollment | 70 |
| Est. completion date | December 2014 |
| Est. primary completion date | April 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Age >18 years; scheduled for thoracic surgery on the suspicion/confirmed lung tumor via open thoracotomy or Visual Assisted Thoracotomy(includes primary lung cancer, metastases from other cancer sites without activity within none year, other tumor types requiring resection of lung tissue; Furthermore, for RCT, one of the following: Age = 70 years or FEV1 = 70% predicted or DLCO = 70% predicted or scheduled pneumonectomy) Exclusion Criteria: - physical or mental deficits that adversely influence physical performance; can neither speak nor read Danish; previous ipsilateral lung resection; tumor activity in other sites or organs; pancoast tumor |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Department of Cardiothoracic Surgery, Aalborg Universityhospital | Aalborg |
| Lead Sponsor | Collaborator |
|---|---|
| Aalborg Universitetshospital | Katholieke Universiteit Leuven, Örebro University, Sweden, University Hospital Orebro |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Change in walking distance, 6 minute | Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery | before surgery, 5th postoperative day and 2 weeks after surgery | No |
| Other | Change in spirometry values(FVC, FEV1) | Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery | before surgery, 5th day, 2 weeks after surgery | No |
| Other | Change in Borg CR-10 dyspnea | Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery | Before surgery, 5th postoperative day and 2 weeks after surgery | No |
| Other | Change in EORTC QLQ-C30-LC13 | Before surgery and 2 weeks after surgery | No | |
| Other | Change in EQ-5D-5L | Before surgery and 2 weeks after surgery | No | |
| Other | Change in Physical Activity Score- PAS | Before surgery and 2 weeks after surgery | No | |
| Other | Change in numeric rang score for pain | Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery | Before surgery, 5th postoperative day and 2 weeks after surgery | No |
| Other | Change in numeric rang score for cough efficiency | 5th postoperative day and 2 weeks after surgery | No | |
| Primary | Change in inspiratory muscle strength | Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery | Before surgery, 5.postoperative day, 2 weeks after surgery | No |
| Secondary | Change in expiratory muscle strength | Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery | Before surgery, 5 th postoperative day and 2 weeks after surgery | No |
| Secondary | Incidence of postoperative pulmonary complications | 2 weeks after surgery | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|